These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5381906)

  • 1. [Blood coagulation in Cushing's and Addison's disease].
    Pisarskaia IV; Sharova IuA
    Sov Med; 1969 Aug; 32(8):118-21. PubMed ID: 5381906
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of naloxone on plasma adrenocorticotropin levels and beta-endorphin-like immunoreactivity in bilaterally adrenalectomized patients with Cushing's disease and in Addison's disease.
    Kasperlik-Załuska A; Jeske W; Migdalska B; Soszyński P; Wiśniewska-Woźniak T
    Acta Med Pol; 1986; 27(3-4):131-9. PubMed ID: 2833071
    [No Abstract]   [Full Text] [Related]  

  • 3. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.
    Restituto P; Galofré JC; Gil MJ; Mugueta C; Santos S; Monreal JI; Varo N
    Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma corticotrophin estimations in Addison's disease and following adrenalectomy for Cushing's disease.
    Sirett NE; Purves HD
    J Clin Endocrinol Metab; 1968 Sep; 28(9):1367-9. PubMed ID: 4300562
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations on the size of lymphocytes in the blood in Addison's disease; panhypopituitarism, and Cushing's syndrome during treatment.
    HERNBERG CA
    Acta Med Scand; 1953; 144(5):380-94. PubMed ID: 13050344
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential blood counts in certain adrenal cortical disorders (Cushing's syndrome, Addison's disease and panhypopituitarism).
    DE LA BALZE FA; REIFENSTEIN EC; ALBRIGHT F
    J Clin Endocrinol Metab; 1946 Apr; 6():312-9. PubMed ID: 21025124
    [No Abstract]   [Full Text] [Related]  

  • 7. [Addison's disease and Cushing's syndrome].
    Ibayashi H; Motohashi K
    Naika; 1967 Jun; 19(6):1073-8. PubMed ID: 4865498
    [No Abstract]   [Full Text] [Related]  

  • 8. [Iatrogenic Cushing's disease in a patient with Addison's disease].
    Rodríguez Cuartero A; Rodríguez Cuartero F
    Rev Clin Esp; 1980 Feb; 156(4):287-9. PubMed ID: 7394212
    [No Abstract]   [Full Text] [Related]  

  • 9. The adrenal gland and the use of cortisone in the management of patients with Addison's disease and Cushing's syndrome.
    O'Daniel LG
    AANA J; 1983 Feb; 51(1):31-7. PubMed ID: 6858574
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of atrial natriuretic factor on basal and stimulated pituitary-adrenal function in Cushing's and Addison's disease.
    Sala C; Ambrosi B; Colombo P; Ardeleani G; Bochicchio D; Gazzano G; Zanchetti A; Morganti A
    J Hypertens Suppl; 1993 Dec; 11(5):S312-3. PubMed ID: 8158401
    [No Abstract]   [Full Text] [Related]  

  • 11. [The blood coagulation system and cortisol metabolism in Itsenko-Cushing disease].
    Vasiukova EA; Pisarskaia IV; Skvortsova RI
    Ter Arkh; 1969 Jul; 41(7):85-8. PubMed ID: 5374416
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anabolic steroid preparations and blood coagulation system in patients with Cushing's disease].
    Vasiukova EA; Pisarskaia IB
    Klin Med (Mosk); 1969 Jul; 47(7):90-2. PubMed ID: 5385098
    [No Abstract]   [Full Text] [Related]  

  • 13. [Calcium and phosphorus metabolism disorders in Cushing's syndrome and Addison's disease].
    Miyazaki T; Araki Y
    Nihon Rinsho; 1978 Oct; 36(10):3385-91. PubMed ID: 722893
    [No Abstract]   [Full Text] [Related]  

  • 14. [Potassium metabolism in the light of the stress signs. III. Potassium treatment and complementary measures].
    MAHNERT E
    Wien Med Wochenschr; 1955 Oct; 105(41):844-6. PubMed ID: 13291820
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the control of ACTH secretion].
    Sorge F; Bayer JM; Retiene K; Mentzel HE; Pfeiffer EF
    Verh Dtsch Ges Inn Med; 1965; 71():267-70. PubMed ID: 4291175
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibodies directed against adrenal glands in Addison's and Cushing's diseases].
    Jeske W; Gajl-Peczalska K; Kasperlik-Zaluska A
    Pol Arch Med Wewn; 1971 Nov; 47(5):485-91. PubMed ID: 5133428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [43. Cushing, Conn, Addison--highs and lows of hormones].
    Stiefelhagen P
    MMW Fortschr Med; 2003 Apr; 145(16):I-X; quiz XI-XII. PubMed ID: 14606407
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemopoietic changes in certain adreno-pituitary diseases].
    RIABOV SI
    Ter Arkh; 1958 Jun; 30(6):31-7. PubMed ID: 13569357
    [No Abstract]   [Full Text] [Related]  

  • 20. [Itsenko-Cushing syndrome evoked by steroid therapy during Addison's disease].
    Ryskind RR; Anosova LN
    Klin Med (Mosk); 1967 Jul; 45(7):118-20. PubMed ID: 5607729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.